Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15675112rdf:typepubmed:Citationlld:pubmed
pubmed-article:15675112lifeskim:mentionsumls-concept:C0086911lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C0041714lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C0033213lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1578603lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1578604lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1549021lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1550014lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1578605lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C1706387lld:lifeskim
pubmed-article:15675112lifeskim:mentionsumls-concept:C0871599lld:lifeskim
pubmed-article:15675112pubmed:issue6lld:pubmed
pubmed-article:15675112pubmed:dateCreated2005-1-28lld:pubmed
pubmed-article:15675112pubmed:abstractTextThis study explores the ethical issues contained in warning letters (WLs) issued to institutional review boards (IRBs) by the United States Food and Drug Administration (FDA).lld:pubmed
pubmed-article:15675112pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15675112pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15675112pubmed:keywordhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15675112pubmed:languageenglld:pubmed
pubmed-article:15675112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15675112pubmed:citationSubsetElld:pubmed
pubmed-article:15675112pubmed:statusMEDLINElld:pubmed
pubmed-article:15675112pubmed:monthDeclld:pubmed
pubmed-article:15675112pubmed:issn0147-958Xlld:pubmed
pubmed-article:15675112pubmed:authorpubmed-author:BramstedtKatr...lld:pubmed
pubmed-article:15675112pubmed:authorpubmed-author:KassimatisKat...lld:pubmed
pubmed-article:15675112pubmed:issnTypePrintlld:pubmed
pubmed-article:15675112pubmed:volume27lld:pubmed
pubmed-article:15675112pubmed:ownerNLMlld:pubmed
pubmed-article:15675112pubmed:authorsCompleteYlld:pubmed
pubmed-article:15675112pubmed:pagination316-23lld:pubmed
pubmed-article:15675112pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:meshHeadingpubmed-meshheading:15675112...lld:pubmed
pubmed-article:15675112pubmed:year2004lld:pubmed
pubmed-article:15675112pubmed:articleTitleA study of warning letters issued to institutional review boards by the United States Food and Drug Administration.lld:pubmed
pubmed-article:15675112pubmed:affiliationResearch Subject Advocacy Program, General Clinical Research Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. bioethics@go.comlld:pubmed
pubmed-article:15675112pubmed:publicationTypeJournal Articlelld:pubmed